摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aα,5α,6α,7aα)-bis(phenylmethyl) (hexahydro-2,2-dimethyl-1,3-benzodioxole-5,6-diyl)bis(carbamate) | 135619-11-3

中文名称
——
中文别名
——
英文名称
(3aα,5α,6α,7aα)-bis(phenylmethyl) (hexahydro-2,2-dimethyl-1,3-benzodioxole-5,6-diyl)bis(carbamate)
英文别名
benzyl N-[(3aS,5S,6R,7aR)-2,2-dimethyl-6-(phenylmethoxycarbonylamino)-3a,4,5,6,7,7a-hexahydro-1,3-benzodioxol-5-yl]carbamate
(3aα,5α,6α,7aα)-bis(phenylmethyl) (hexahydro-2,2-dimethyl-1,3-benzodioxole-5,6-diyl)bis(carbamate)化学式
CAS
135619-11-3
化学式
C25H30N2O6
mdl
——
分子量
454.523
InChiKey
IHBSGGXYYGFYIX-COPRSSIGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    33
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    95.1
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    (3aα,5α,6α,7aα)-bis(phenylmethyl) (hexahydro-2,2-dimethyl-1,3-benzodioxole-5,6-diyl)bis(carbamate) 在 palladium on activated charcoal 1,2,2,6,6-五甲基哌啶盐酸氢气 、 sodium hydride 作用下, 以 1,4-二氧六环甲醇N,N-二甲基甲酰胺 为溶剂, 25.0~75.0 ℃ 、137.9 kPa 条件下, 反应 26.0h, 生成 (1α,2α,4β,5β)-4,4'-(4,5-dihydroxy-1,2-cyclohexanediyl)bis(2,6-piperazinedione)
    参考文献:
    名称:
    Syntheses and proton NMR conformational analyses of diastereomeric 4,4'-(4,5-dihydroxy-1,2-cyclohexanediyl)bis(2,6-piperazinedione)s and a synthetically related tricyclic octahydro-2,2-dimethyl-6-oxo-1,3-dioxolo[4,5-g]quinoxaline-5,8-diacetic acid ester
    摘要:
    Efficient syntheses for five of the six possible diastereoisomeric 4,4'-(4,5-dihydroxy-1,2-cyclohexanediyl)bis-(2,6-dioxopiperazine)s (5-9) and a synthetically related tricyclic 1,3-dioxolo[4,5-g]quinoxaline ring system 45 from their respective (4,5-dihydroxy-1,2-cyclohexanediyl)bis(carbamate)s 11-16 via isopropylidene-protected intermediates are described. Solution conformations of all targets and several synthetic intermediates in DMSO-d6 were determined using H-1 NMR and NOE methods, and the structure for polyheterocycle 45, obtained during attempted preparation of the sixth possible dioxopiperazine diastereomer 10, was determined with the additional aid of 2D COSY, 2D HETCOR, and H-1-C-13 correlation of long-range coupling (COLOC). Taken together, these studies provide evidence for the differences in reaction conditions required for bis(dioxopiperazine) synthesis, a relatively comprehensive analysis of dioxopiperazine and hydroxyl substituent effects on cyclohexane DMSO-d6 solution conformations, and a preliminary analysis of aqueous solubility differences.
    DOI:
    10.1021/jo00018a039
  • 作为产物:
    描述:
    2-甲氧基丙烯 、 bis(phenylmethyl) (1α,2α,4β,5β)-(4,5-dihydroxy-1,2-cyclohexanediyl)bis(carbamate) 在 对甲苯磺酸 作用下, 以 丙酮 为溶剂, 以88%的产率得到(3aα,5α,6α,7aα)-bis(phenylmethyl) (hexahydro-2,2-dimethyl-1,3-benzodioxole-5,6-diyl)bis(carbamate)
    参考文献:
    名称:
    Syntheses and proton NMR conformational analyses of diastereomeric 4,4'-(4,5-dihydroxy-1,2-cyclohexanediyl)bis(2,6-piperazinedione)s and a synthetically related tricyclic octahydro-2,2-dimethyl-6-oxo-1,3-dioxolo[4,5-g]quinoxaline-5,8-diacetic acid ester
    摘要:
    Efficient syntheses for five of the six possible diastereoisomeric 4,4'-(4,5-dihydroxy-1,2-cyclohexanediyl)bis-(2,6-dioxopiperazine)s (5-9) and a synthetically related tricyclic 1,3-dioxolo[4,5-g]quinoxaline ring system 45 from their respective (4,5-dihydroxy-1,2-cyclohexanediyl)bis(carbamate)s 11-16 via isopropylidene-protected intermediates are described. Solution conformations of all targets and several synthetic intermediates in DMSO-d6 were determined using H-1 NMR and NOE methods, and the structure for polyheterocycle 45, obtained during attempted preparation of the sixth possible dioxopiperazine diastereomer 10, was determined with the additional aid of 2D COSY, 2D HETCOR, and H-1-C-13 correlation of long-range coupling (COLOC). Taken together, these studies provide evidence for the differences in reaction conditions required for bis(dioxopiperazine) synthesis, a relatively comprehensive analysis of dioxopiperazine and hydroxyl substituent effects on cyclohexane DMSO-d6 solution conformations, and a preliminary analysis of aqueous solubility differences.
    DOI:
    10.1021/jo00018a039
点击查看最新优质反应信息

文献信息

  • Ethylenediamine derivatives
    申请人:——
    公开号:US20040122063A1
    公开(公告)日:2004-06-24
    The invention relates a compound represented by the formula (1): Q 1 -Q 2 -C(═O)—N(R 1 )-Q 3 -N(R 2 )-T 1 -Q 4 ( 1 ) wherein R 1 and R 2 represent H or the like; Q 1 represents an aromatic ring, heterocyclic ring or the like; Q 2 represents a single bond, aromatic ring, heterocyclic ring or the like; Q 3 represents a group 1 or the like, Q 4 represents an aromatic ring, heterocyclic ring or the like; and T 1 represents —CO— or —SO 2 —, and a medicine which comprises the compound and is useful for thrombosis and embolism.
    本发明涉及一种由式(1)表示的化合物:Q1-Q2-C(═O)—N(R1)-Q3-N(R2)-T1-Q4(1),其中R1和R2代表H或类似物;Q1代表芳香环,杂环或类似物;Q2代表单键,芳香环,杂环或类似物;Q3代表群1或类似物,Q4代表芳香环,杂环或类似物;T1代表—CO—或—SO2—,以及包含该化合物并对治疗血栓和栓塞有用的药物。
  • ETHYLENEDIAMINE DERIVATIVES
    申请人:Daiichi Sankyo Company, Limited
    公开号:EP1270557B1
    公开(公告)日:2012-07-25
  • Monoacylated 1,2-diaminocycloalkanes
    申请人:Daiichi Sankyo Company, Limited
    公开号:EP2431370B1
    公开(公告)日:2013-06-19
  • US7192968B2
    申请人:——
    公开号:US7192968B2
    公开(公告)日:2007-03-20
  • Syntheses and proton NMR conformational analyses of diastereomeric 4,4'-(4,5-dihydroxy-1,2-cyclohexanediyl)bis(2,6-piperazinedione)s and a synthetically related tricyclic octahydro-2,2-dimethyl-6-oxo-1,3-dioxolo[4,5-g]quinoxaline-5,8-diacetic acid ester
    作者:Donald T. Witiak、Yong Wei
    DOI:10.1021/jo00018a039
    日期:1991.8
    Efficient syntheses for five of the six possible diastereoisomeric 4,4'-(4,5-dihydroxy-1,2-cyclohexanediyl)bis-(2,6-dioxopiperazine)s (5-9) and a synthetically related tricyclic 1,3-dioxolo[4,5-g]quinoxaline ring system 45 from their respective (4,5-dihydroxy-1,2-cyclohexanediyl)bis(carbamate)s 11-16 via isopropylidene-protected intermediates are described. Solution conformations of all targets and several synthetic intermediates in DMSO-d6 were determined using H-1 NMR and NOE methods, and the structure for polyheterocycle 45, obtained during attempted preparation of the sixth possible dioxopiperazine diastereomer 10, was determined with the additional aid of 2D COSY, 2D HETCOR, and H-1-C-13 correlation of long-range coupling (COLOC). Taken together, these studies provide evidence for the differences in reaction conditions required for bis(dioxopiperazine) synthesis, a relatively comprehensive analysis of dioxopiperazine and hydroxyl substituent effects on cyclohexane DMSO-d6 solution conformations, and a preliminary analysis of aqueous solubility differences.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐